Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Co-Primary Analysis The active comparator analysis comparing dual therapy versus GLP-1 RA monotherapy (N = 13,782 matched pairs) demonstrated that dual therapy was associated with lower colon cancer risk compared with GLP-1 RA monotherapy alone (115 events [0.8%] vs 179 events [1.3%]
Int J Mol Sci 21(24):9710 Page MJ et al (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
00306-5/asset/4528bbae-a780-434c-942e-17e63964c626/main.assets/gr2_lrg.jpg)
Disclosures Dr Sannino has received research grants from Edwards Lifesciences and Venus Medtech
In this new study, we expanded the range of cancers investigated to include less common types that have rarely been investigated
10.1038/ijo.2013.149 183
US$ 27.17
US$ 21.39
US$ 28.77
US$ 27.61
US$ 29.85
